{"schema_version":"secwatch.filing_event.v1","accession":"0000784199-23-000130","form_type":"8-K","ticker":"AORT","cik":"0000784199","company_name":"ARTIVION, INC.","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.644789+00:00","generated_at":"2026-06-12T10:15:21.362126+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Artivion Q2 revenue $89.3M (+11% YoY); raises FY revenue guidance to $342-350M","bullets":["Net loss ($3.4M) or ($0.08)/share; non-GAAP net income $2.3M ($0.06)/share.","Non-GAAP adjusted EBITDA $13.8M, up 35% YoY.","Aortic stent graft revenue +19% YoY; On-X +11% constant currency.","Received $14.3M PerClot PMA approval milestone payment from Baxter.","FY 2023 constant currency revenue growth guidance raised to 10%-12%."],"urls":{"canonical":"https://secwatch.observer/filing/0000784199-23-000130","json":"https://secwatch.observer/filing/0000784199-23-000130.json","markdown":"https://secwatch.observer/filing/0000784199-23-000130.md","text":"https://secwatch.observer/filing/0000784199-23-000130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000130/0000784199-23-000130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000130/aort-20230803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T10:15:21.362126+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9e03e73a0982ee31bdcabd1de5f3e38ad500b864","claim":"ARTIVION, INC. reported the second quarter ended June 30, 2023 results: revenue $89.3 million, net income ($3.4) million, EPS ($0.08) per share. Guidance raised.","evidence_excerpt":"• Achieved revenue of $89.3 million in the second quarter of 2023 versus $80.3 million in the second quarter of 2022, an increase of 11% on both a GAAP and non-GAAP constant currency basis • Net loss was ($3.4) million or ($0.08) per share;","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000130/0000784199-23-000130-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended June 30, 2023"},{"label":"Revenue","value":"$89.3 million"},{"label":"Net income","value":"($3.4) million"},{"label":"EPS","value":"($0.08) per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}